1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95.0%, 250mg

3-CHLORO-5-METHYL-4-HYDROXYBENZONITRILE, 95.0%, 1g

1,4-dithiepan-6-one, 95.0%, 1g

6-Bromo-3-methylbenzo[d]isoxazole, 95.0%, 250mg

(5-Bromopentyl)boronic acid, 95.0%, 100mg

1-(Aminomethyl)cyclopentanol hydrochloride, 95.0%, 1g

(4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid, 97.0%, 1g

2,6-Dibromo-4-methylaniline, 98.0%, 100g

Glass packaging wool 11 µm, glass packaging according to DIN 1259-1, 1 kg, plastic packaging.

1-Pyrimidin-2-yl-piperidin-4-ol, 95.0%, 1g

2-(5-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

3-(4-bromo-2-fluorophenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

2-Chloro-3-nitroisonicotinic acid, 95.0%, 1g